Inactive Instrument

Highlights POIT BIOP

Equities

RACA

US7305411099

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Fusion Pharmaceuticals an 'Attractive' Takeover Target Following Recent Radiopharma Deals, Oppenheimer Says	12-27	MT
Fusion Pharmaceuticals 'Last Available Target' With Solid Supply Chain After Point Biopharma, RayzeBio Takeovers, Oppenheimer Says	12-27	MT
Eli Lilly: successful takeover bid for POINT Biopharma Global	12-27	CF
Eli Lilly Completes Acquisition of Point Biopharma Global	12-27	MT
Eli Lilly Closes $1.4 Billion Takeover of Point Biopharma	12-27	MT
Eli Lilly and Company completed the acquisition of POINT Biopharma Global Inc. from Joe A. McCann, Allan Charles Silber, Neil E. Fleshner and others.	12-26	CI
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition to Dec. 22	12-18	MT
Eli Lilly: further extension of takeover bid for Point Biopharma Global	12-18	CF
Lantheus Holdings, Inc. and POINT Biopharma Global Inc. Announce Positive Topline Results from Pivotal Splash Trial in Metastatic Castration-Resistant Prostate Cancer	12-18	CI
Eli Lilly Further Extends Tender Offer Deadline for Point Biopharma Shares	12-18	MT
Eli Lilly: further extension of its tender offer for POINT Biopharma	12-04	CF
Eli Lilly Extends Tender Offer for POINT Biopharma to Dec. 15	12-04	MT
Eli Lilly Extends Tender Offer Period for Point Biopharma Global Acquisition	12-04	MT
Eli Lilly extends tender offer to buy Point Biopharma	12-04	RE
Eli Lilly: has extended its tender offer for Point Biopharma	11-20	CF
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition	11-17	MT
Point Biopharma Holders Resisting Eli Lilly Tender Offer	11-17	DJ
Eli Lilly Extends Tender Offer for Point Biopharma Acquisition at $12.50 a Share to Dec. 1	11-17	MT
Eli Lilly Extends Tender Offer for Point Biopharma	11-17	MT
Lilly extends tender offer to acquire Point Biopharma to Dec 1	11-17	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights POIT BIOP

Equities

RACA

US7305411099

Highlights

Filters